Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history.
作者信息
Issa Danny, Alkhouri Naim
机构信息
The Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University, Richmond, VA, USA.
The Texas Liver Institute, San Antonio, TX, USA.
出版信息
Hepatobiliary Surg Nutr. 2017 Dec;6(6):401-403. doi: 10.21037/hbsn.2017.07.07.
Abstract
摘要
相似文献
1
Nonalcoholic fatty liver disease and hepatocellular carcinoma: new insights on presentation and natural history.非酒精性脂肪性肝病与肝细胞癌：关于临床表现和自然史的新见解
Hepatobiliary Surg Nutr. 2017 Dec;6(6):401-403. doi: 10.21037/hbsn.2017.07.07.
2
Obesity and hepatocellular carcinoma.肥胖与肝细胞癌
Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. doi: 10.1053/j.gastro.2004.09.021.
3
Nonalcoholic fatty liver disease in the pediatric population: a review.儿科人群中的非酒精性脂肪性肝病：综述
Curr Opin Pediatr. 2005 Oct;17(5):636-41. doi: 10.1097/01.mop.0000172816.79637.c5.
4
Role of nonalcoholic fatty liver disease in hepatocellular carcinoma.非酒精性脂肪性肝病在肝细胞癌中的作用。
Ann Hepatol. 2009;8 Suppl 1:S34-9.
5
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.非酒精性脂肪性肝病诊断和治疗实践指南。意大利肝病学会（AISF）专家委员会十项建议。
Dig Liver Dis. 2010 Apr;42(4):272-82. doi: 10.1016/j.dld.2010.01.021. Epub 2010 Feb 19.
6
Hepatocellular carcinoma disguised as liver abscesses.伪装成肝脓肿的肝细胞癌。
Proc (Bayl Univ Med Cent). 2018 Mar 20;31(2):222-223. doi: 10.1080/08998280.2018.1444252. eCollection 2018 Apr.
7
[Research on the natural history of non-alcoholic fatty liver disease should be taken seriously].[应重视非酒精性脂肪性肝病自然史的研究]
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):81-84. doi: 10.3760/cma.j.issn.1007-3418.2017.02.001.
8
Magnitude of Nonalcoholic Fatty Liver Disease: Eastern Perspective.非酒精性脂肪性肝病的严重程度：东方视角
J Clin Exp Hepatol. 2019 Jul-Aug;9(4):491-496. doi: 10.1016/j.jceh.2019.01.007. Epub 2019 Feb 7.
9
Fatty liver and the metabolic syndrome.脂肪肝与代谢综合征
Curr Opin Gastroenterol. 2007 Mar;23(2):193-8. doi: 10.1097/MOG.0b013e32801421a9.
10
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease-hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective.非酒精性脂肪性肝炎/非酒精性脂肪性肝病-肝细胞癌的自然史：从肝病诊所角度看问题的严重程度。
Clin Liver Dis (Hoboken). 2016 Oct 27;8(4):100-104. doi: 10.1002/cld.579. eCollection 2016 Oct.
引用本文的文献
1
Toll-like receptors in health and disease.健康与疾病中的Toll样受体
MedComm (2020). 2024 Apr 29;5(5):e549. doi: 10.1002/mco2.549. eCollection 2024 May.
2
A Shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to Hepatocellular Carcinoma (HCC): c-MYC a Promising Target for Preventative Strategies and Individualized Therapy.从代谢相关脂肪性肝病（MAFLD）到肝细胞癌（HCC）的一条捷径：c-MYC——预防策略和个体化治疗的一个有前景的靶点。
Cancers (Basel). 2021 Dec 31;14(1):192. doi: 10.3390/cancers14010192.
3
Disease severity predicts higher healthcare costs among hospitalized nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH) patients in Spain.在西班牙，疾病严重程度预示着住院的非酒精性脂肪性肝病/非酒精性脂肪性肝炎（NAFLD/NASH）患者的医疗费用更高。
Medicine (Baltimore). 2020 Dec 11;99(50):e23506. doi: 10.1097/MD.0000000000023506.
4
Adlay Seed ( L.) Extracts Exhibit a Prophylactic Effect on Diet-Induced Metabolic Dysfunction and Nonalcoholic Fatty Liver Disease in Mice.薏仁提取物对饮食诱导的小鼠代谢功能障碍和非酒精性脂肪性肝病具有预防作用。
Evid Based Complement Alternat Med. 2020 May 29;2020:9519625. doi: 10.1155/2020/9519625. eCollection 2020.
5
2019 Update of Indian National Association for Study of the Liver Consensus on Prevention, Diagnosis, and Management of Hepatocellular Carcinoma in India: The Puri II Recommendations.印度肝脏研究全国协会关于印度肝细胞癌预防、诊断和管理的共识2019年更新：普里II建议
J Clin Exp Hepatol. 2020 Jan-Feb;10(1):43-80. doi: 10.1016/j.jceh.2019.09.007. Epub 2019 Sep 23.
6
Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy.靶向长链酰基辅酶 A 合成酶用于癌症治疗。
Int J Mol Sci. 2019 Jul 24;20(15):3624. doi: 10.3390/ijms20153624.
7
Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function.饮用脱咖啡因咖啡可预防早期非酒精性脂肪性肝炎的发生：肠道屏障功能的作用。
Redox Biol. 2019 Feb;21:101092. doi: 10.1016/j.redox.2018.101092. Epub 2018 Dec 23.
8
Hepatic expression of Yin Yang 1 (YY1) is associated with the non-alcoholic fatty liver disease (NAFLD) progression in patients undergoing bariatric surgery.阴阳1（YY1）的肝脏表达与接受减肥手术患者的非酒精性脂肪性肝病（NAFLD）进展相关。
BMC Gastroenterol. 2018 Oct 3;18(1):147. doi: 10.1186/s12876-018-0871-2.
9
MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.微小 RNA-378 通过调节 NF-κB-TNFα 通路促进肝炎症和纤维化。
J Hepatol. 2019 Jan;70(1):87-96. doi: 10.1016/j.jhep.2018.08.026. Epub 2018 Sep 13.
本文引用的文献
1
Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.非酒精性脂肪性肝炎肝硬化患者接受肝细胞癌监测的可能性显著降低。
Dig Dis Sci. 2017 Aug;62(8):2174-2181. doi: 10.1007/s10620-017-4595-x. Epub 2017 May 4.
2
Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis.肝硬化患者肝细胞癌监测中超声检查质量合格的预测因素
Aliment Pharmacol Ther. 2017 Jan;45(1):169-177. doi: 10.1111/apt.13841. Epub 2016 Nov 8.
3
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.全球非酒精性脂肪性肝病流行病学——患病率、发病率和结局的荟萃分析评估。
Hepatology. 2016 Jul;64(1):73-84. doi: 10.1002/hep.28431. Epub 2016 Feb 22.
4
Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: A multicenter prospective study.非酒精性脂肪性肝病相关肝细胞癌的临床特征：一项多中心前瞻性研究。
Hepatology. 2016 Mar;63(3):827-38. doi: 10.1002/hep.28368. Epub 2016 Jan 14.
5
Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma.高胰岛素血症与胰岛素信号传导在肝细胞癌发病机制及临床病程中的作用
Liver Int. 2015 Oct;35(10):2203-17. doi: 10.1111/liv.12903. Epub 2015 Jul 23.
6
Characteristics of hepatocellular carcinoma in cirrhotic and non-cirrhotic non-alcoholic fatty liver disease.肝硬化和非肝硬化非酒精性脂肪性肝病中肝细胞癌的特征
World J Gastroenterol. 2015 Jan 28;21(4):1189-96. doi: 10.3748/wjg.v21.i4.1189.
7
Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review.基于系统综述的非酒精性脂肪性肝病与肝细胞癌风险的相关性。
Clin Gastroenterol Hepatol. 2012 Dec;10(12):1342-1359.e2. doi: 10.1016/j.cgh.2012.10.001. Epub 2012 Oct 4.
8
Abdominal obesity, weight gain during adulthood and risk of liver and biliary tract cancer in a European cohort.腹部肥胖、成年期体重增加与欧洲队列人群肝癌和胆道癌风险的关系
Int J Cancer. 2013 Feb 1;132(3):645-57. doi: 10.1002/ijc.27645. Epub 2012 Jun 13.
9
Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.肥胖和脂毒性在非酒精性脂肪性肝炎发展中的作用：病理生理学和临床意义。
Gastroenterology. 2012 Apr;142(4):711-725.e6. doi: 10.1053/j.gastro.2012.02.003. Epub 2012 Feb 8.
10
Hepatocellular carcinoma.肝细胞癌
N Engl J Med. 2011 Sep 22;365(12):1118-27. doi: 10.1056/NEJMra1001683.
Zotero 插件